about
Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.Surveillance of Patients in the Waiting Area of the Department of Emergency Medicine.Mild therapeutic hypothermia improves outcomes compared with normothermia in cardiac-arrest patients--a retrospective chart review.The incidence of "load&go" out-of-hospital cardiac arrest candidates for emergency department utilization of emergency extracorporeal life support: A one-year review.Emergency extracorporeal life support and ongoing resuscitation: a retrospective comparison for refractory out-of-hospital cardiac arrest.Emergency cardio-pulmonary bypass in cardiac arrest: seventeen years of experience.Limited effect of mild therapeutic hypothermia on outcome after prolonged resuscitation.Outcome of in- and out-of-hospital cardiac arrest survivors with liver cirrhosis.Cardiac arrest caused by acute intoxication-insight from a registry.Dispatchers impression plus Medical Priority Dispatch System reduced dispatch centre times in cases of out of hospital cardiac arrest. Pre-alert--a prospective, cluster randomized trial.Updated teaching techniques improve CPR performance measures: a cluster randomized, controlled trial.Exercise related cardiac arrest in amateur athletes on the tennis court.Initial electrical frequency predicts survival and neurological outcome in out of hospital cardiac arrest patients with pulseless electrical activity.Post-resuscitation care at the emergency department with critical care facilities--a length-of-stay analysis.Out of hospital cardiac arrest in Vienna: incidence and outcomeNeurologic causes of cardiac arrest and outcomes
P50
Q33589789-CF2CE44C-02DE-457B-A7DF-30D7497902BBQ36421048-1909E0CC-CBB8-479E-B01D-FE9C1AEF9BEFQ38012593-74EBD128-3E87-44E5-BDFF-D289647B7FD4Q38380777-1FE33E84-89EE-4E64-8F5F-0DA6FB172F38Q38954511-E021A56F-A602-4DDD-84D8-4AC9F7A17071Q39585348-C517D16E-387C-4C72-88F4-AF7EB8E6E7DCQ41201349-430C369B-3FE0-40B2-9A23-207DA1371B00Q42371761-A78864F1-A41E-4CAB-80C9-192D84D9DE94Q43435221-14E3D44D-1320-4E78-97CD-CAE25E70E345Q46120382-C28E5AEF-7C52-4466-B2B0-21E75AA7056FQ48148639-EE138992-249A-4E39-9FE9-2309944FEEC6Q48530151-B0854043-2669-4033-AEE5-7555AC36B4B4Q50169007-62F73035-3EFC-4D41-A5BC-9B506621D230Q51475811-B49FB4BB-D06E-48E3-9FD5-BDF440BF8C18Q84574038-186CD040-FD40-490E-8A95-A00914F63DA6Q85749046-0AC1E9B2-7F31-4060-86F3-7603D6F1EA75
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christoph Weiser
@ast
Christoph Weiser
@en
Christoph Weiser
@es
Christoph Weiser
@nl
Christoph Weiser
@sl
type
label
Christoph Weiser
@ast
Christoph Weiser
@en
Christoph Weiser
@es
Christoph Weiser
@nl
Christoph Weiser
@sl
prefLabel
Christoph Weiser
@ast
Christoph Weiser
@en
Christoph Weiser
@es
Christoph Weiser
@nl
Christoph Weiser
@sl
P106
P31
P496
0000-0001-5521-1268